Nuvalent Inc (NUVL)
70.95
-1.69
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
70.95
0.00 (0.00%)
After-Hours: 20:00
Nuvalent Accounts Payable (Quarterly): 13.40M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.40M |
| December 31, 2023 | 9.274M |
| September 30, 2023 | 9.781M |
| June 30, 2023 | 8.117M |
| March 31, 2023 | 6.433M |
| December 31, 2022 | 7.195M |
| September 30, 2022 | 4.62M |
| Date | Value |
|---|---|
| June 30, 2022 | 4.028M |
| March 31, 2022 | 4.246M |
| December 31, 2021 | 2.893M |
| September 30, 2021 | 2.532M |
| June 30, 2021 | 3.798M |
| March 31, 2021 | 1.449M |
| December 31, 2020 | 1.252M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.252M
Minimum
Dec 2020
13.40M
Maximum
Mar 2024
5.644M
Average
4.433M
Median
Accounts Payable (Quarterly) Benchmarks
| Geron Corp | 9.992M |
| Verastem Inc | 7.449M |
| Karyopharm Therapeutics Inc | 5.028M |
| Syndax Pharmaceuticals Inc | 16.36M |
| AnaptysBio Inc | 4.582M |